Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Alfa-1 Antitrypsinmangel

Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Unipolar psychotic depression

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Metastaserende basalcellekarcinom

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Endoskopisk behandling af hydrocefalus

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Intracerebral hæmoragi tolv dage efter vaccination med ChAdOx1 nCoV-19

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Selvskade er et stigende problem, men der er håb forude

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. The Association between Use of ICS and Psychiatric Symptoms in Patients with COPD—A Nationwide Cohort Study of 49,500 Patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Heart failure associated with imported malaria: a nationwide Danish cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Treatment Response Biomarkers in Asthma and COPD

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Incidence and impact of parvovirus B19 infection in seronegative solid organ transplant recipients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

The subject of this review is alpha-1-antitrypsin deficiency (A1AD), which is a rare hereditary disease with great impact in adults, especially smokers, quality of life and longevity. Early diagnosis is crucial for treatment outcome. The primary care physician should refer patients younger than 50-years-old with COPD or emphysema, familiar accumulation of A1AD or liver cirrhosis of unknown cause. Most important treatment is smoking cessation, pulmonary rehabilitation and inhaled medication according to current guidelines. Substitution treatment with alpha-1-antitrypsin is now an option after its approval by the Danish medical council in January 2020.

Bidragets oversatte titelAlpha-1-antitrypsin deficiency
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind183
Udgave nummer30
ISSN0041-5782
StatusUdgivet - 26 jul. 2021

    Forskningsområder

  • Adult, Humans, Liver Cirrhosis, Middle Aged, Pulmonary Emphysema/etiology, Quality of Life, Smoking Cessation, alpha 1-Antitrypsin Deficiency/complications

ID: 67060931